+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antiarrhythmic"

From
From
Arrhythmia Global Market Report 2024 - Product Thumbnail Image

Arrhythmia Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
From
From
Hypertrophic Cardiomyopathy - Pipeline Insight, 2023 - Product Thumbnail Image

Hypertrophic Cardiomyopathy - Pipeline Insight, 2023

  • Clinical Trials
  • July 2023
  • 60 Pages
  • Global
From
From
From
From
From
Cardiovascular Drugs: Global Markets to 2022 - Product Thumbnail Image

Cardiovascular Drugs: Global Markets to 2022

  • Report
  • March 2018
  • 174 Pages
  • Global
From
Potassium channel antagonists - Pipeline Insight, 2022 - Product Thumbnail Image

Potassium channel antagonists - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
  • Global
From
Cardiac Arrythmia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cardiac Arrythmia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Sodium channel blockers - Pipeline Insight, 2022 - Product Thumbnail Image

Sodium channel blockers - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The antiarrhythmic market is a subset of the cardiovascular drug market, which includes drugs used to treat abnormal heart rhythms. Antiarrhythmic drugs are used to treat arrhythmias, which are abnormal heart rhythms that can cause symptoms such as palpitations, dizziness, and chest pain. These drugs work by blocking or slowing down electrical signals in the heart, restoring the normal rhythm. Common types of antiarrhythmic drugs include beta blockers, calcium channel blockers, and potassium channel blockers. The antiarrhythmic market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Other companies in the market include Bristol-Myers Squibb, AstraZeneca, and Boehringer Ingelheim. Show Less Read more